Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Total 13F shares
-
373,099,760
-
Share change
-
+1,851,978
-
Total reported value
-
$42,233,817,121
-
Put/Call ratio
-
98%
-
Price per share
-
$113.24
-
Number of holders
-
901
-
Value change
-
+$225,153,200
-
Number of buys
-
445
-
Number of sells
-
348
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2022
As of 31 Dec 2022 DEXCOM INC - Common Stock (DXCM) had 901 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 373,099,760 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, FMR LLC, JPMORGAN CHASE & CO, Capital Research Global Investors, JENNISON ASSOCIATES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 901 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.